Inspired by analysis from Andrew Mooney of Broughton Group and broader discussions emerging from ATNF 2026. The U.S. Food and Drug Administration’s recent nicotine pouch pilot program may prove to be one of the most consequential regulatory developments for reduced-risk nicotine products in years, not because it lowered standards, but because it demonstrated that speed…
Recent research published in the American Journal of Preventive Medicine provides updated evidence on nicotine pouch use among adults in the United States, offering new insights into usage patterns, population trends, and potential regulatory considerations. The study, Nicotine Pouch Use Among U.S. Adults in 2023 and 2024, examines nationally representative data to assess how use…
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how taxation frameworks and market surveillance systems are shaping the regulation and development of alternative nicotine products across the EU and beyond. The session was moderated by Ciprian Boboi and featured contributions from Tomasz Płaska, Leonhard Kipphan, and Lorenzo…
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a panel session exploring the factors influencing consumer adoption of new nicotine products, focusing on innovation, accessibility, and regulatory context. The session was moderated by Marc Reisner and featured contributions from Waqas Khan, Vincent Reid, and John Dunne, offering perspectives from manufacturing, distribution, and…
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how evolving EU regulatory frameworks, including the Tobacco Products Directive (TPD3) and the Tobacco Taxation Directive (TTD), are shaping the future of nicotine product governance from policy design to market implementation. The session was chaired by Peter Beckett and…
At EVO NXT 2026, the Global Institute for Novel Nicotine hosted a deep dive session examining how evolving EU taxation frameworks are shaping the regulation, availability, and market dynamics of alternative nicotine products. The session was hosted by Joel Rubenstein and featured contributions from Johan Nissinen, Ciprian Boboi, Vlad Olteanu, and Tomasz Płaska, bringing together…
At EVO NXT 2026, the Global Institute for Novel Nicotine opened its programme with a panel session examining the latest scientific evidence, regulatory frameworks, and public health considerations surrounding tobacco harm reduction. The session was moderated by Philipp Markl and featured contributions from Dr Sydney Hiller, Sairah Salim-Sartoni, and John Dunne, bringing together perspectives from…
EVO NXT 2026 officially opened on April 17, 2026, at Forum Karlín in Prague, bringing together stakeholders from across the next-generation products (NGP) sector, including manufacturers, regulators, researchers, and public health representatives. Positioned as a business-focused event, EVO NXT serves as a platform for examining how innovation, regulation, and market developments are shaping the future…
Over the last decade, smoking has fallen across most high-income countries, but not at the same pace. In some jurisdictions, the decline has been steep; in others, more gradual and persistent. This variation is not solely explained by cultural or economic factors. It reflects differences in regulatory design and how policymakers approach nicotine use. This…
The nicotine pouch category is evolving rapidly across global markets, driven by regulatory shifts, growing consumer adoption, and strategic investment from major industry players. At GINN, we are building an AI-powered monitoring system designed to track global nicotine and oral product developments with greater speed, accuracy, and relevance. The concept is simple: AI scans hundreds…